* TELA Bio Inc TELA.OQ reported a quarterly adjusted loss
of 57 cents per share for the quarter ended in June. The mean
expectation of four analysts for the quarter was for a loss
of 52 cents per share.
* Revenue rose 116.4% to $7.59 million from a year ago;
analysts expected $6.31 million.
* TELA Bio Inc's reported EPS for the quarter was a loss of 57
cents.
* The mean earnings estimate of analysts had fallen by
about 3.5% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* TELA Bio Inc shares had fallen by 17.4% this quarter and
lost 11.5% so far this year.
* The company reported a quarterly loss of $8.26 million.
* Wall Street's median 12-month price target for TELA Bio Inc is
$20.00
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated August 11 at 08:48 p.m. All
figures in US dollars unless otherwise stated